| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.44 | 0.009 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |